Sign Up

What Can DUPIXENT MyWay® do for You?

Fill out this form to get the latest information about DUPIXENT, exclusive tools and resources to help you understand and manage your condition. Plus, see if you're eligible for the DUPIXENT MyWay Copay Card.

What Can DUPIXENT MyWay® Do for You?

You must be 18 years of age or older to sign up.
You must be 18 years of age or older to sign up.
You must be 18 years or older to sign up.
The patient must be 12 years of age or older to sign up.
Your Information:

Patient Information:

Patient information collected is for copay card purposes only. Marketing communications will not be sent to patients under the age of 18.

I acknowledge that by checking the Text Messaging Consent box, I expressly consent to receive text messages from or on behalf of the Program at the mobile telephone number(s) that I provide. I confirm that I am the subscriber for the mobile telephone number(s) provided, and I agree to notify Sanofi promptly if any of my number(s) change in the future. I understand that my wireless service provider's message and data rates may apply. I understand that I can opt out from future text messages at any time by texting SMSSTOP to 39771 from my mobile phone, and that I can get help for text messages by texting SMSHELP to 39771. I also understand that additional text messaging terms and conditions may be provided to me in the future as part of an opt-in confirmation text message. I understand that my consent is not required as a condition of purchasing any goods or services from Regeneron Pharmaceuticals, Inc. or Sanofi. Message and data rates may apply.

View Terms and Conditions and Privacy Policy.

You are not eligible to register for a new copay card or to activate a copay card. However, you can receive support from DUPIXENT MyWay by joining our email list. Just check the box below and submit this form.
You are not eligible to register for a new copay card or to activate a copay card. However, you can receive support from DUPIXENT MyWay by joining our email list. Just submit this form.

I am enrolling in the DUPIXENT MyWay Program (the "Program") and authorize Regeneron Pharmaceuticals, Inc., Sanofi US, and their agents (together the "Alliance") to provide me services under the program, and as may be added in the future. Such services include medication and adherence communications and support, medication dispensing support, coverage and financial assistance support, disease and medication education, injection training and other support services (the "Services").

I agree to my enrollment in the DUPIXENT MyWay Copay Card program if confirmed as eligible, understand that copay card information will be sent to my designated specialty pharmacy/in-network specialty pharmacy along with my prescription, and any assistance with my applicable cost-sharing or co-payment for DUPIXENT (dupilumab) will be made in accordance with the Program terms and conditions.

I authorize the Alliance to contact me by mail, telephone, or email, with information about the Program, moderate-to-severe eczema (atopic dermatitis) and products, promotions, services and research studies, and to ask my opinion about such information and topics, including market research and disease-related surveys.

I further authorize the Alliance to de-identify my health information and use it in performing research, education, business analytics, marketing studies or for other commercial purposes. I understand that members of the Alliance may share identifiable health information with one another in order to de-identify it for these purposes and as needed to perform the Services or to send the communications listed above (the "Communications"). I understand and agree that the Alliance may use my health information for these purposes and may share my health information with my doctors, specialty pharmacies, and insurers.

I understand that I do not have to enroll in the Program or receive the Communications, and that I can still receive DUPIXENT, as prescribed by my physician. I may opt out of receiving Communications, individual support services offered by the Program, including the DUPIXENT MyWay Copay Card, or opt out of the Program entirely at any time by notifying a Program representative by telephone at 1-800-633-1610 or by sending a letter to Sanofi US Customer Service P.O. Box 5925 Mailstop 55A-220A Bridgewater, NJ 08807. I also understand that the Services may be revised, changed, or terminated at any time.

Questions or comments? Contact Sanofi US, or call 1-844-643-7346 to contact Regeneron Pharmaceuticals, Inc.

By clicking 'Submit,' I confirm that all information provided in this form is true, complete and accurate.

I am enrolling in the DUPIXENT MyWay Program (the "Program") and authorize Regeneron Pharmaceuticals, Inc., Sanofi US, and their agents (together the "Alliance") to provide me services under the program, and as may be added in the future. Such services include medication and adherence communications and support, medication dispensing support, coverage and financial assistance support, disease and medication education, injection training and other support services (the "Services").

I authorize the Alliance to contact me by mail, telephone, or email, with information about the Program, moderate-to-severe eczema (atopic dermatitis) and products, promotions, services and research studies, and to ask my opinion about such information and topics, including market research and disease-related surveys.

I further authorize the Alliance to de-identify my health information and use it in performing research, education, business analytics, marketing studies or for other commercial purposes. I understand that members of the Alliance may share identifiable health information with one another in order to de-identify it for these purposes and as needed to perform the Services or to send the communications listed above (the "Communications"). I understand and agree that the Alliance may use my health information for these purposes and may share my health information with my doctors, specialty pharmacies, and insurers.

I understand that I do not have to enroll in the Program or receive the Communications, and that I can still receive DUPIXENT, as prescribed by my physician. I may opt out of receiving Communications, individual support services offered by the Program or opt out of the Program entirely at any time by notifying a Program representative by telephone at 1-800-633-1610 or by sending a letter to Sanofi US Customer Service P.O. Box 5925 Mailstop 55A-220A Bridgewater, NJ 08807. I also understand that the Services may be revised, changed, or terminated at any time.

Questions or comments? Contact Sanofi US, or call 1-844-643-7346 to contact Regeneron Pharmaceuticals, Inc.

By clicking 'Submit,' I confirm that all information provided in this form is true, complete and accurate.